去氢骆驼蓬碱联合rad51抑制剂对细粒棘球蚴体外作用及DNA损伤水平的影响

doi:10.12140/j.issn.1000-7423.2024.06.006

中国寄生虫学与寄生虫病杂志 ›› 2024, Vol. 42 ›› Issue (6): 726-736.doi: 10.12140/j.issn.1000-7423.2024.06.006

去氢骆驼蓬碱联合rad51抑制剂对细粒棘球蚴体外作用及DNA损伤水平的影响

巩月红¹^,²^,³(), 潘美驰⁴, 孙佳佳⁵, 马瑞佳⁶, 吾斯曼江·艾买提⁷, 赵一聪⁴, 赵军¹^,²^,³, 王建华¹^,²^,³^,^*()

1 新疆医科大学第一附属医院药学部，新疆乌鲁木齐 830011
2 新疆医科大学省部共建中亚高发病成因与防治国家重点实验室，新疆乌鲁木齐 830011
3 新疆药物临床研究重点实验室，新疆乌鲁木齐 830011
4 新疆医科大学药学院，新疆乌鲁木齐 830054
5 新疆医科大学临床医学部，新疆乌鲁木齐 830054
6 新疆医科大学第七附属医院药学部，新疆乌鲁木齐 830092
7 新疆喀什地区第二人民医院药学部，新疆喀什 844000

收稿日期:2024-05-22 修回日期:2024-07-19 出版日期:2024-12-30 发布日期:2025-01-14
通讯作者: *王建华（1964—），女，研究生，主任药师。从事抗棘球蚴病新药与作用机制研究。E-mail：jhw716@163.com
作者简介:巩月红（1976—），女，研究生，副主任药师。从事抗棘球蚴病新药与作用机制研究。E-mail：gongyh0602@126.com
基金资助:
新疆维吾尔自治区科学技术厅自然科学基金重点项目(2021D01D15);新疆维吾尔自治区天山英才青年骨干项目(TSYC202301B095);省部共建国家重点实验室开放课题(SKL-HIDCA-2022-9)

Effect of harmine combined with rad51 inhibitor on the Echinococcus granulosus larvae and its DNA damage in vitro

GONG Yuehong¹^,²^,³(), PAN Meichi⁴, SUN Jiajia⁵, MA Ruijia⁶, WUSMANJIANG Aimaiti⁷, ZHAO Yicong⁴, ZHAO Jun¹^,²^,³, WANG Jianhua¹^,²^,³^,^*()

1 Department of Pharmacy, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang, China
2 State Key Laboratory of Causes and Prevention of High Morbidity in Central Asia, Xinjiang Medical University, Urumqi 830011, Xinjiang, China
3 Xinjiang Key Laboratory of Clinical Drug Research, Urumqi 830011, Xinjiang, China
4 Department of Pharmacognosy, School of Pharmacy, Xinjiang Medical University, Urumqi 830054, Xinjiang, China
5 Department of Medicine, School of Pharmacy, Xinjiang Medical University, Urumqi 830054, Xinjiang, China
6 Department of Pharmacy, The Seventh Affiliated Hospital of Xinjiang Medical University,Urumqi 830092, Xinjiang, China
7 Department of Pharmacy, The Second People’s Hospital of Kashgar, Xinjiang, Kashi 844000, Xinjiang, China

Received:2024-05-22 Revised:2024-07-19 Online:2024-12-30 Published:2025-01-14
Contact: *E-mail: jhw716@163.com
Supported by:
Natural Science Foundation of Xinjiang Uygur Autonomous Region(2021D01D15);“Tianshan Talents” Program for Training High-level Talents in Medicine and Healthcare(TSYC202301B095);State Key Laboratory of Pathogenesis, Prevention and Treatment of Central Asia High Incidence Diseases fund(SKL-HIDCA-2022-9)

摘要/Abstract

摘要：

目的探讨去氢骆驼蓬碱联合rad51抑制剂（RI-1）对细粒棘球蚴体外作用及DNA损伤水平的影响。方法从绵羊肝脏的棘球蚴包囊中收集细粒棘球蚴，随机分组，各组分别用去氢骆驼蓬碱（0、20、30、40、50、100 μg/ml）与RI-1（0、5、10、20、40、80 μg/ml）培养5 d，0.1%亚甲基蓝染色计算存活率，选择接近去氢骆驼蓬碱抗细粒棘球蚴半抑制浓度组别的浓度为固定浓度，分别以去氢骆驼蓬碱与RI-1比例分别为40∶5、40∶10、40∶20的混合药物干预细粒棘球蚴，筛选最佳协同比例。设置去氢骆驼蓬碱和RI-1混合药物组，同浓度单独作用的去氢骆驼蓬碱组和RI-1组，并设置阳性对照组（添加阿苯达唑亚砜）与空白对照组，观察干预3 d后细粒棘球蚴与囊泡形态。DCFH-DA法检测各组干预后细粒棘球蚴活性氧含量；各组进行彗星实验（阳性对照为阿霉素），分析并测定Olive尾矩；试剂盒检测药物干预后细粒棘球蚴氧化应激水平及Caspase-3含量，以及三磷酸腺苷（ATP）和乳酸脱氢酶（LDH）含量；qRT-PCR反应检测DNA损伤修复相关基因的mRNA相对表达水平。结果 0、20、30、40、50、100 μg/ml的去氢骆驼蓬碱干预5 d后细粒棘球蚴存活率分别为（94.67 ± 1.25）%、（83.00 ± 3.27）%、（64.67 ± 3.86）%、（55.33 ± 3.40）%、（29.67 ± 2.49）%、（9.33 ± 1.70）%，0、5、10、20、40、80 μg/ml的RI-1干预5 d后细粒棘球蚴存活率分别为（94.33 ± 0.94）%、（70.00 ± 2.94）%、（55.67 ± 3.86）%、（30.00 ± 5.09）%、（2.67 ± 1.25）%、0。以40 μg/ml∶10 μg/ml作为混合药物最佳协同比例干预细粒棘球蚴3 d后，混合药物组存活率为（48.67 ± 2.62）%，与空白对照组[（96.33 ± 1.25）%]、阳性对照组[（91.67 ± 1.25）%]、去氢骆驼蓬碱组[（72.67 ± 4.50）%]相比均下降（F = 78.85，P < 0.01；F = 437.92, P < 0.05；F = 42.49，P < 0.01）。混合药物组虫体结构塌陷，形态破坏严重，虫体显著缩小且表皮层呈现虫蚀样改变。混合药物组活性氧平均荧光强度（45.71 ± 1.52）与空白对照组（3.40 ± 0.55）、阳性对照组（12.98 ± 0.67）、去氢骆驼蓬碱组（39.79 ± 1.11）相比均增强（F = 339.795、773.96、76.99，均P < 0.01）。混合药物组Olive尾矩值（17.73 ± 1.11）高于空白对照组（0.03 ± 0.02）、阳性对照组（6.46 ± 0.56）和去氢骆驼蓬碱组（8.80 ± 0.61）（F = 230.32、165.59、151.44，均P < 0.01）。混合药物组总超氧化物歧化酶（SOD）含量为（0.71 ± 0.07）U/mg，与空白对照组[（2.32 ± 0.24）U/mg]、去氢骆驼蓬碱组[（1.26 ± 0.12）U/mg]相比均降低（F = 39.57、 15.74，均P < 0.01）；混合药物组丙二醛（MDA）含量为（0.62 ± 0.03）mmol/mg，与空白对照组[（0.82 ± 0.05）mmol/mg]、去氢骆驼蓬碱组[（0.70 ± 0.03）mmol/mg]相比均降低（F = 22.78、28.37，P < 0.01）；混合药物组Caspase-3水平为（1.82 ± 0.05）U/mg，与空白对照组[（0.70 ± 0.02）U/mg]、去氢骆驼蓬碱组为[（1.36 ± 0.19）U/mg]相比均升高（F = 26.24，P < 0.01；F = 7.52，P < 0.05）。混合药物组细粒棘球蚴线粒体ATP水平为（112.21 ± 2.72）µmol/ml，与空白对照组[（157.50 ± 5.23）µmol/ml]、去氢骆驼蓬碱组[（123.10 ± 4.73）µmol/ml]相比均降低（F = 60.73，P < 0.01；F = 67.42，P < 0.05）。混合药物组细粒棘球蚴LDH释放量为（1.83 ± 0.09）mU，与空白对照组[（0.70 ± 0.05）mU]相比升高（F = 146.79，P < 0.01），与去氢骆驼蓬碱组[（1.51 ± 0.05）mU]相比差异无统计学意义（F = 62.78，P > 0.05）。混合药物组细粒棘球蚴h2ax、rad51、brca1、mre11基因相对表达水平分别为2.34 ± 0.15、1.19 ± 0.14、1.35 ± 0.08、1.43 ± 0.10，与空白对照组（均为1.00 ± 0.00）相比均上调（F = 23.79，P < 0.01；F = 8.96，P < 0.05；F = 30.75，P < 0.05；F = 39.81，P < 0.01）。结论去氢骆驼蓬碱联合rad51抑制剂RI-1可增强去氢骆驼蓬碱体外抗细粒棘球蚴的作用，同时增强细粒棘球蚴DNA损伤。

关键词: 细粒棘球蚴, 去氢骆驼蓬碱, rad51抑制剂, 存活率, DNA损伤

Abstract:

Objective To investigate the effect of harmine combined with rad51 inhibitor (RI-1) on Echinococcus granulosus in vitro and the level of DNA damage. Methods E. granulosus from the cysts of sheep liver were collected and randomly divided into groups. Each group contains a mixture of harmine (0, 20, 30, 40, 50, 100 μg/ml) and RI-1 (0, 5, 10, 20, 40, 80 μg/ml), cultured for 5 days, and stained with 0.1% methylene blue to calculate the survival rate. The group which is close to the half inhibitory concentration of harmine against E. granulosus was selected as the fixed concentration. The groups were treated against E. granulosus with a mixture of harmine and RI-1 in ratios of 40∶5, 40∶10 and 40∶20, respectively. The optimal synergistic ratio was screened. Set up a mixed drug group of harmine and RI-1, a harmine group and RI-1 group acting alone at the same concentration, and set up a positive control group (adding albendazole sulfoxide) and a blank control group. Observe the morphology of E. granulosus and vesicles after 3 days of intervention. DCFH-DA method was used to detect the reactive oxygen species content of E. granulosus after intervention in each group. Each group underwent comet assay (the positive control was doxorubicin), and the Olive tail moment was analyzed and measured. The reagent kit is used to detect the oxidative stress level and Caspase-3 content of E. granulosus after drug intervention, as well as the levels of adenosine triphosphate (ATP) and lactate dehydrogenase (LDH). qRT-PCR reaction is used to detect the mRNA expression levels of DNA damage repair related genes. Results The survival rates of E. granulosus after 5 days of intervention with 0, 20, 30, 40, 50 and 100 μg/ml harmine were (94.67 ± 1.25)%, (83.00 ± 3.27)%, (64.67 ± 3.86)%, (55.33 ± 3.40)%, (29.67 ± 2.49)%, and (9.33 ± 1.70)%, respectively. The survival rates of E. granulosus after 5 days of intervention with 0, 5, 10, 20, 40 and 80 μg/ml RI were (94.33 ± 0.94)%, (70.00 ± 2.94)%, (55.67 ± 3.86)%, and (30.00 ± 1.70)%, 5.09%, (2.67 ± 1.25)% and 0, respectively. After 3 days of intervention with a mixed drug ratio of 40 μg/ml∶10 μg/ml as the optimal synergistic ratio for E. granulosus, the survival rate of the mixed drug group was (48.67 ± 2.62)%, which was lower than that of the blank control group [(96.33 ± 1.25)%], positive control group [(91.67 ± 1.25)%], and harmine group [(72.67 ± 4.50)%] (F = 78.85, P < 0.01; F = 437.92, P < 0.05; F = 42.49, P < 0.01). The structure of the mixed drug group’s worm body collapsed, with severe morphological damage, significant shrinkage of the worm body, and insect like changes in the epidermal layer. The average fluorescence intensity of reactive oxygen species in the mixed drug group (45.71 ± 1.52) was enhanced compared with the blank control group (3.40 ± 0.55), the positive control group (12.98 ± 0.67), and the dehydroberberine group (39.79 ± 1.11) (F = 339.795, 773.96, 76.99, all P < 0.01). The Olive tail moment value of the mixed drug group (17.73 ± 1.11) was higher than that of the blank control group (0.03 ± 0.02), positive control group (6.46 ± 0.56), and dehydrocamel base group (8.80 ± 0.61) (F = 230.32, 165.59, 151.44, all P < 0.01). The SOD content in the mixed drug group was (0.71 ± 0.07) U/mg, which was lower than that in the blank control group [(2.32 ± 0.24) U/mg] and the dehydroberberine group [(1.26 ± 0.12) U/mg] (F = 39.57, 15.74, both P < 0.01). The MDA content in the mixed drug group was (0.62 ± 0.03) mmol/mg, which was lower than that in the blank control group [(0.82 ± 0.05) mmol/mg] and the dehydroberberine group [(0.70 ± 0.03) mmol/mg] (F = 22.78, 28.37, P < 0.01). The level of Caspase-3 in the mixed drug group was (1.82 ± 0.05) U/mg, which was higher than that in the blank control group [(0.70 ± 0.02) U/mg] and the dehydroberberine group [(1.36 ± 0.19) U/mg] (F = 26.24, P < 0.01; F = 7.52, P < 0.05). The mitochondrial ATP level of E. granulosus in the mixed drug group was (112.21 ± 2.72) µmol/ml, which was lower than that of the blank control group [(157.50 ± 5.23) µmol/ml] and the dehydrocoumarin group [(123.10 ± 4.73) µmol/ml] (F = 60.73, P < 0.01; F = 67.42, P < 0.05). The release of LDH from E. granulosus in the mixed drug group was (1.83 ± 0.09) mU, which was higher than that in the blank control group [(0.70 ± 0.05) mU] (F = 146.79, P < 0.01), but there was no statistically significant difference compared with the dehydrocoumarin group [(1.51 ± 0.05) mU] (F = 62.78, P > 0.05). The relative expression levels of h2ax, rad51, brca1 and mrel1 genes in the mixed drug group of E. granulosus were 2.34 ± 0.15, 1.19 ± 0.14, 1.35 ± 0.08, and 1.43 ± 0.10, respectively, which were upregulated compared with the blank control group (all 1.00 ± 0.00) (F = 23.79, P < 0.01; F = 8.96, P < 0.05; F = 30.75, P < 0.05; F = 39.81, P < 0.01). Conclusion The combination of harmine and rad51 inhibitor RI-1 can enhance the in vitro efficacy of harmine against E. granulosus, while also increasing DNA damage in E. granulosus.

Key words: Echinococcus granulosus, Harmine, rad51 inhibitor, Survival, DNA damage

中图分类号:

R383.3

巩月红, 潘美驰, 孙佳佳, 马瑞佳, 吾斯曼江·艾买提, 赵一聪, 赵军, 王建华. 去氢骆驼蓬碱联合rad51抑制剂对细粒棘球蚴体外作用及DNA损伤水平的影响[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(6): 726-736.

GONG Yuehong, PAN Meichi, SUN Jiajia, MA Ruijia, WUSMANJIANG Aimaiti, ZHAO Yicong, ZHAO Jun, WANG Jianhua. Effect of harmine combined with rad51 inhibitor on the Echinococcus granulosus larvae and its DNA damage in vitro[J]. Chinese Journal of Parasitology and Parasitic Diseases, 2024, 42(6): 726-736.

图/表 9

表1

图1

图2

图3

图4

图5

图6

表2

图7

参考文献 25

[1]	Ozturk EA, Manzano-Román R, Sánchez-Ovejero C, et al. Comparison of the multi-epitope recombinant antigen DIPOL and hydatid fluid for the diagnosis of patients with cystic echinococcosis[J]. Acta Trop, 2022, 225: 106208.
[2]	Aasen TD, Nasrollah L, Seetharam A. Drug-induced liver failure requiring liver transplant: report and review of the role of albendazole in managing echinococcal infection[J]. Exp Clin Transplant, 2018, 16(3): 344-347 doi: 10.6002/ect.2015.0313 pmid: 27228108
[3]	Zhang L, Li DC, Yu SL. Pharmacological effects of harmine and its derivatives: a review[J]. Arch Pharm Res, 2020, 43(12): 1259-1275. doi: 10.1007/s12272-020-01283-6 pmid: 33206346
[4]	Yu T, Wang LL, Zhao HQ, et al. Current status and outlook of vaccine development for Echinococcus granulosus[J]. J Pathog Biol, 2024, 19(1): 107-112. (in Chinese)
	(于涛, 王利磊, 赵慧卿, 等. 细粒棘球蚴病疫苗的研制现状[J]. 中国病原生物学杂志, 2024, 19(1): 107-112.
[5]	Gong YH, Zhao ML, Ma RJ, et al. Effects of harmine inducing apoptosis on mitochondrial fusion and division in PC12 cells[J]. Her Med, 2024, 43(2): 174-183. (in Chinese)
	(巩月红, 赵美玲, 马瑞佳, 等. 去氢骆驼蓬碱诱发PC12细胞凋亡时对线粒体融合分裂的影响[J]. 医药导报, 2024, 43(2): 174-183.)
[6]	Gong YH, Tian CY, Lu S, et al. Harmine combined with Rad54 knockdown inhibits the viability of Echinococcus granulosus by enhancing DNA damage[J]. DNA Cell Biol, 2021, 40(1): 1-9.
[7]	Lu S, Wen LM, Gong YH, et al. In vitro effects of harmine against Echinococcus granulosus protoscoleces by stimulating DNA damage[J]. Exp Parasitol, 2021, 226/227: 108121.
[8]	Tang SM, Yu HP, Wei QY. DNA mismatch repair gene variants/mutations and cancer treatment response[J]. Chin J Oncol Prev Treat, 2023, 15(6): 593-601. (in Chinese)
	(汤绍梅, 余红平, 魏庆义. DNA错配修复基因的遗传变异/突变与肿瘤治疗反应[J]. 中国癌症防治杂志, 2023, 15(6): 593-601.)
[9]	Govindaraj V, Keralapura Basavaraju R, Rao AJ. Changes in the expression of DNA double strand break repair genes in primordial follicles from immature and aged rats[J]. Reprod Biomed Online, 2015, 30(3): 303-310. doi: 10.1016/j.rbmo.2014.11.010 pmid: 25599822
[10]	Titus S, Li F, Stobezki R, et al. Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans[J]. Sci Transl Med, 2013, 5(172): 172ra21.
[11]	Liu RW, Li MB, Hu ZX, et al. Research advances of RAD51AP1 in tumor progression and drug resistance[J]. Chin J Lung Cancer, 2023, 26(9): 701-708. (in Chinese)
	(刘仁旺, 李明彪, 胡子轩, 等. RAD51AP1在肿瘤进展和耐药中的研究进展[J]. 中国肺癌杂志, 2023, 26(9): 701-708.)
[12]	Kui Y, Xue CZ, Wang X, et al. Progress of echinococcosis control in China, 2022[J]. Chin J Parasitol Parasit Dis, 2024, 42(1): 8-16. (in Chinese)
	(蒉嫣, 薛垂召, 王旭, 等. 2022年全国棘球蚴病防治工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(1): 8-16.) doi: 10.12140/j.issn.1000-7423.2024.01.002
[13]	Du YF, Jiang HJ, Liu CH, et al. Sunitinib in combination with albendazole for the treatment of alveolar echinococcosis[J]. J Shihezi Univ Nat Sci, 2023, 41(5): 599-607. (in Chinese)
	(杜云峰, 姜慧娇, 刘程豪, 等. 舒尼替尼与阿苯达唑联合用药对泡状棘球蚴治疗效果的实验研究[J]. 石河子大学学报(自然科学版), 2023, 41(5): 599-607.) doi: 10.13880/j.cnki.65-1174/n.2023.22.037
[14]	Qin M, Wang LY. Research progress on combined use of drugs with albendazole in the treatment of echinococcosis[J]. Chin J Parasitol Parasit Dis, 2022, 40(5): 647-655. (in Chinese)
	(秦敏, 王立英. 阿苯达唑联合药物治疗棘球蚴病的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(5): 647-655.) doi: 10.12140/j.issn.1000-7423.2022.05.013
[15]	Gong YH, Gao HJ, Lu S, et al. Evaluation of the effects of Caspase-3 and antioxidase activity during the death of Echinococcus granulosus induced by harmine in vitro[J]. J Pathog Biol, 2018, 13(11): 1207-1210. (in Chinese)
	(巩月红, 高惠静, 卢帅, 等. 去氢骆驼蓬碱体外诱导细粒棘球蚴原头节凋亡过程中caspase-3及抗氧化酶活性检测分析[J]. 中国病原生物学杂志, 2018, 13(11): 1207-1210.)
[16]	Gao Y, Lu S, Tian CY, et al. Detection of Echinococcus granulosus genes related to repair of DNA damage caused by harmine[J]. J Pathog Biol, 2020, 15(1): 32-36. (in Chinese)
	(高旖, 卢帅, 田春艳, 等. 去氢骆驼蓬碱致细粒棘球蚴DNA损伤修复相关基因表达量的检测[J]. 中国病原生物学杂志, 2020, 15(1): 32-36.)
[17]	Li CH, Mi Y, Ren FF, et al. Effects of luteolin on DNA double-strand breaks and homologous recombination repair in human gastric cancer cells[J]. Chin J Gastroenterol Hepatol, 2023, 32(4): 385-391. (in Chinese)
	(李冲慧, 米阳, 任飞飞, 等. 木犀草素对人胃癌细胞DNA双链断裂及同源重组修复的影响[J]. 胃肠病学和肝病学杂志, 2023, 32(4): 385-391.)
[18]	Budke B, Logan HL, Kalin JH, et al. RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells[J]. Nucleic Acids Res, 2012, 40(15): 7347-7357. doi: 10.1093/nar/gks353 pmid: 22573178
[19]	Vaz F, Hanenberg H, Schuster B, et al. Mutation of the RAD51C gene in a Fanconi Anemia-like disorder[J]. Nat Genet, 2010, 42(5): 406-409.
[20]	Li Y, Chen QZ, Fan LX, et al. Quercetin affects both DNA repair and ROS level to improve radiosensitivity of NSCLC cells[J]. Pharmacol Clin Chin Mater Med, 2023, 39(11): 62-67. (in Chinese)
	(李怡, 陈其章, 范临夏, 等. 槲皮素协同影响DNA修复和ROS水平提高NSCLC细胞的放疗敏感性[J]. 中药药理与临床, 2023, 39(11): 62-67.)
[21]	Liu MS. Study on the mechanism of DNA damage and apoptosis induced by endogenous ROS in hair follicle cycle[D]. Changchun: Jilin University, 2023. (in Chinese)
	(刘明圣. 内源性ROS诱导的DNA损伤和细胞凋亡在毛囊周期中的效应机制研究[D]. 长春: 吉林大学, 2023.)
[22]	Chen H, Xu PX, Wang HZ, et al. Roles of H2AX phosphorylation in DNA damage and repair and its study in reproduction-related cells[J]. Chem Life, 2023, 43(12): 1896-1906. (in Chinese)
	(陈红, 徐沛欣, 王惠增, 等. DNA损伤和修复中的H2AX磷酸化及其在生殖相关细胞中的作用[J]. 生命的化学, 2023, 43(12): 1896-1906.)
[23]	Zheng YF, Yang F, Guo ZG. Roles of homologous recombination repair protein Rad51 in cancer[J]. Chem Life, 2022, 42(10): 1874-1880. (in Chinese)
	(郑云峰, 杨帆, 郭泽庚. 同源重组修复蛋白Rad51在癌症中的作用[J]. 生命的化学, 2022, 42(10): 1874-1880.)
[24]	Bhutia RD, Sherpa ML, Singh TA, et al. Oxidative stress in metabolic syndrome & its association with DNA-strand break[J]. Indian J Med Res, 2018, 148(4): 435-440.
[25]	Godin SK, Sullivan MR, Bernstein KA. Novel insights into RAD51 activity and regulation during homologous recombination and DNA replication[J]. Biochim Biol Cell, 2016, 94(5): 407-418.

名称 Name	序列（5'→3'） Sequences（5'→3'）
mre11	F：GAGTTCCAAGCAGTGACCAGTCTG
mre11	R：CCACTCGGCTGACGCAATCG
brca1	F：TGATTGCGACCTAAGAGAC
brca1	R：TTCCATACACAAGCCATCC
h2ax	F：TTTGGCTTCACGGCTGGCTATG
h2ax	R：TGAGTTTGCTGGAAGGGAAATGGG
rad51	F：GGCACTGATGGTGGCAATCTCC
rad51	R：CAGAAGATCCGCTCCACTTATCGC
β-actin	F：GCGATGTATGTAGCTATCCAGGCAGTGCTCTCGCT
β-actin	R：CAATCCAGACAGAGTATTTGCGTTCCGGAGGA

组别 Group	ATP/µmol·mg^-1	LDH/mU
空白对照组 Blank control group	157.50 ± 5.23	0.70 ± 0.05
去氢骆驼蓬碱组 Harmine group	123.10 ± 4.73	1.51 ± 0.05
RI-1组 RI-1 group	149.94 ± 1.94	1.16 ± 0.02
混合药物组 Mixed drug group	112.21 ± 2.72	1.83 ± 0.09

去氢骆驼蓬碱联合rad51抑制剂对细粒棘球蚴体外作用及DNA损伤水平的影响

Effect of harmine combined with rad51 inhibitor on the Echinococcus granulosus larvae and its DNA damage in vitro

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 9

参考文献 25

相关文章 15

编辑推荐

Metrics

本文评价

[1]	孙莉, 卢恩昌, 程猛, 艾艳红. 1例潜伏感染25年肝细粒棘球蚴病报告[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(6): 817-819.
[2]	汪占金, 陈志恒, 李富源, 蔡俊杰, 薛张佗, 周瀛, 曹云太, 王展. 基于影像组学及临床特征的机器学习模型鉴别肝细粒棘球蚴病病灶活性的研究[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(5): 582-593.
[3]	任艳, 宋涛, 尚丰, 吴淼, 王正业, 王晓荣. 卷积神经网络在辅助肝细粒棘球蚴病超声分型诊断的应用[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(4): 454-460.
[4]	吴易璇, 郭小腊, 陈轶霞. 细粒棘球蚴感染绵羊血清miRNA差异表达及诊断价值评价[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(3): 295-302.
[5]	候梦丹, 吉古孝安, 刘伟伟, 邱美龄, 胡美荷, 李昆雷, 加依娜尔·吉克散巴依, 翟少华. 绵羊肝细粒棘球蚴包囊形成不同时期的病理学变化观察[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(3): 316-324.
[6]	李昆雷, 夏俊, 邱美龄, 胡美荷, 吉古孝安, 候梦丹, 翟少华. 抗寄生虫中药活性成分体外抗细粒棘球蚴作用[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(2): 191-198.
[7]	蒉嫣, 薛垂召, 王旭, 刘白雪, 王莹, 王立英, 杨诗杰, 韩帅, 许学年. 2022年全国棘球蚴病防治工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(1): 8-16.
[8]	逯君霞, 许军英, 赵彬, 王芊文, 李文华, 耿玉庆, 侯隽, 吴向未, 陈雪玲. 细粒棘球蚴感染诱导巨噬细胞表达CD73和A2AR抑制炎症反应[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(5): 559-566.
[9]	蒉嫣, 薛垂召, 王旭, 刘白雪, 王莹, 王立英, 杨诗杰, 韩帅, 伍卫平, 肖宁. 2021年全国棘球蚴病防治进展[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(2): 142-148.
[10]	郭刚, 任远, 焦红杰, 武娟, 郭宝平, 齐文静, 李军, 张文宝. 腹腔感染棘球蚴微囊对小鼠肝脏多房棘球蚴感染及致病的影响[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(2): 156-162.
[11]	路伟民, 杨小涛, 朱瑛, 张鸿, 李霁伟, 王艳春. 儿童肺细粒棘球蚴病1例[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(2): 253-256.
[12]	郭璐, 吴小霞, 段兰利, 王冰洁, 徐宁, 阿热艾·阿哈太, 乌云花, 赵莉, 班万里, 陈云英, 余婉蓉, 刘帅, 潘星羽, 吾力江·卡马力, 徐晶, 穆尼拉·特列吾汗, 张壮志. 新疆部分地区牛、羊细粒棘球蚴感染情况调查及基因多态性分析[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(5): 603-609.
[13]	毋德芳, 付永, 任宾, 张耀刚, 许晓磊, 庞明泉, 樊海宁. 青海人源两型棘球绦虫（棘球蚴）遗传多样性及分化时间研究[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(5): 610-615.
[14]	侯娇, 温浩, 王明坤, 蒋铁民, 房彬彬, 李静, 张传山, 王慧. 肝细粒棘球蚴病手术患者病灶活性状态的影响因素分析[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(3): 309-314.
[15]	乔世源, 周雪, 刘程豪, 姜慧娇, 卜媛媛, 陈雪玲, 吴向未. 阿苯达唑载药囊泡对细粒棘球蚴原头节活性的影响[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(3): 324-329.